Stocks and Investing Stocks and Investing
Thu, December 23, 2021
Wed, December 22, 2021
Tue, December 21, 2021
Mon, December 20, 2021
Fri, December 17, 2021

Andrew Berens Maintained (ZNTL) at Buy with Increased Target to $97 on, Dec 17th, 2021


Published on 2024-10-27 19:02:40 - WOPRAI, Andrew Berens
  Print publication without navigation


Andrew Berens of SVB Leerink, Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Buy with Increased Target from $89 to $97 on, Dec 17th, 2021.

Andrew has made no other calls on ZNTL in the last 4 months.



There are 4 other peers that have a rating on ZNTL. Out of the 4 peers that are also analyzing ZNTL, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Andrew


  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $120 on, Thursday, November 11th, 2021
  • Robert Driscoll of "Wedbush" Maintained at Buy with Increased Target to $89 on, Wednesday, October 27th, 2021
  • Bradley Canino of "Stifel" Initiated at Strong Buy and Held Target at $84 on, Thursday, September 30th, 2021
  • Matthew Biegler of "Oppenheimer" Initiated at Buy and Held Target at $90 on, Wednesday, September 29th, 2021